The CDC will distribute 77,000 additional doses of Beyfortus, a respiratory syncytial virus (RSV) drug from Sanofi and AstraZeneca, to deal with shortages and unprecedented demand that has left pediatricians and hospitals struggling to stock the immunization. The doses will be distributed to physicians, hospitals, and through the Vaccines for Children Program.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
